Vertex Pharmaceuticals Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2006 | $161.7M | — | — |
| FY2007 | $213.9M | — | — |
| FY2008 | $175.5M | $-462.7M | $-459.9M |
| FY2009 | $101.9M | $-614.0M | $-642.2M |
| FY2010 | $143.2M | $-696.1M | $-754.6M |
| FY2011 | $1.41B | $113.8M | $29.6M |
| FY2012 | $1.53B | $46.7M | $-107.0M |
| FY2013 | $1.21B | $-610.0M | $-445.0M |
| FY2014 | $580.6M | $-692.4M | $-738.6M |
| FY2015 | $1.03B | $-466.9M | $-556.3M |
| FY2016 | $1.70B | $9.9M | $-112.1M |
| FY2017 | $2.48B | $123.2M | $263.5M |
| FY2018 | $3.05B | $635.2M | $2.10B |
| FY2019 | $4.16B | $1.20B | $1.18B |
| FY2020 | $6.21B | $2.86B | $2.71B |
| FY2021 | $7.60B | $2.78B | $2.34B |
| FY2022 | $8.93B | $4.31B | $3.32B |
| FY2023 | $9.88B | $3.83B | $3.62B |
| FY2024 | $11.02B | $-232.9M | $-535.6M |
| FY2025 | $12.00B | $4.17B | $3.95B |